PLEASANTON, Calif., May 25, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 150 global enterprises and fast-growing companies are advancing clinical trial operations ...

NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, ...

PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use Veeva CTMS to execute faster, ...

The "Clinical Trial Management Systems (CTMS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Clinical Trial Management Systems (CTMS) is ...

PLEASANTON, Calif. , Oct. 17, 2022 /PRNewswire/ -- Veeva Systems (VEEV) (NYSE: VEEV) today announced that 40 contract research organizations (CROs) selected Veeva Vault CTMS to deliver faster and more ...

What important contenders are dominating the Global Clinical Trial Management System (CTMS) Market industry and how competitive will the market be by 2023? Global Clinical Trial Management System ...

Clinical Trial Management Systems (CTMS) were designed to make trial execution inspectable and compliant, and that role remains the backbone of operational control. They are built to log visits, ...

(MENAFN- EIN Presswire) EINPresswire/ -- CTMS module expands the Enlighten Clinical Platform, supporting clearer operational oversight, study coordination, and more efficient trial execution.

PLEASANTON, Calif., May 13, 2021 /PRNewswire/ -- As the need for greater efficiency in studies grows, more than 100 companies are streamlining trial management and monitoring with Veeva Vault CTMS.

Veeva Systems Inc. VEEV recently announced that with the growing need for greater efficiency in clinical studies, more than 100 organizations are simplifying trial management and monitoring via the ...

NEW YORK & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, today announced that Translational Drug Development (TD2), a precision oncology contract research organization ...